Mach-1 Financial Group’s Zymeworks ZYME Stock Holding History

Mach-1 Financial Group’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-63,736	Closed	-$551K	–	267
2023 Q2	$551K	Buy	+63,736	New	+$571K	0.16%	116

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Mach-1 Financial Group's ZYME Position: Q3 2023 in Review

Mach-1 Financial Group sold out of Zymeworks (ZYME) in Q3 2023, closing a stake of 63,736 shares — an estimated $551K sold.

Mach-1 Financial Group first reported a position in ZYME in Q2 2023 and held it in 1 quarter. The position peaked at $551K in Q2 2023. 139 funds tracked by Wall St. Rank hold ZYME as of Q3 2023.

Mach-1 Financial Group reported no remaining Zymeworks position as of Q3 2023 after selling out during the quarter.
Mach-1 Financial Group sold 63,736 Zymeworks shares in Q3 2023, an estimated $551K.
Mach-1 Financial Group first reported a position in Zymeworks in Q2 2023 and held it in 1 quarter.
Mach-1 Financial Group's Zymeworks position peaked at $551K in Q2 2023.
139 funds tracked by Wall St. Rank held Zymeworks as of Q3 2023.

Based on Mach-1 Financial Group's 13F filing for Q3 2023, filed 17 Oct 2023.